D. Bilan and !. , !38! 3.3.1! Recueil'des'données.' 38! 3.3.2! Définitions'

!. Autres, !. Morbimortalité, and !. , !40! 3.3.2.3.2! Inflammation!et!type!histologique!:!

P. , !. Bilan, !. , and !. , !45! 4.1.1! Caractéristiques'des'patients'opérés'pour'MICI'(Cohortes'A

B. Crohn, L. Ginzburg, and G. Oppenheimer, Regional Ileitis, JAMA, vol.251, issue.1, pp.73-82, 1984.
DOI : 10.1001/jama.1984.03340250053024

C. Gower-rousseau, F. Vasseur, M. Fumery, G. Savoye, J. Salleron et al., Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD) Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, 2013.

L. Jr and E. , Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, vol.126, issue.6, pp.1504-1521, 2004.

B. Khor, A. Gardet, and R. Xavier, Genetics and pathogenesis of inflammatory bowel disease, Nature, vol.105, issue.7351, pp.307-324, 2011.
DOI : 10.1038/nature10209

P. Seksik, Gut microbiota and IBD, Gastroent??rologie Clinique et Biologique, vol.34, issue.1, pp.44-51, 2010.
DOI : 10.1016/S0399-8320(10)70020-8

URL : https://hal.archives-ouvertes.fr/hal-00597604

C. Bernstein, J. Blanchard, P. Rawsthorne, and N. Yu, The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study, The American Journal of Gastroenterology, vol.11, issue.3, 2001.
DOI : 10.1016/0049-0172(91)90011-N

P. Juillerat, C. Mottet, V. Pittet, F. Froehlich, C. Felley et al., Extraintestinal Manifestations of Crohn???s Disease, Digestion, vol.76, issue.2, pp.141-149, 2007.
DOI : 10.1159/000111029

M. Silverberg, J. Satsangi, T. Ahmad, I. Arnott, C. Bernstein et al., Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the, Montreal World Congress of Gastroenterology, 2005.

J. Satsangi, M. Silverberg, S. Vermeire, and J. Colombel, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, vol.55, issue.6, 2006.
DOI : 10.1136/gut.2005.082909

J. Panes, Y. Bouhnik, W. Reinisch, J. Stoker, S. Taylor et al., Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines, Journal of Crohn's and Colitis, vol.7, issue.7, pp.556-85, 2013.
DOI : 10.1016/j.crohns.2013.02.020

J. Jass, Classification of colorectal cancer based on correlation of clinical, morphological and molecular features, Histopathology, vol.154, issue.1, pp.113-143, 2007.
DOI : 10.1084/jem.184.3.1075

H. Raskov, H. Pommergaard, J. Burcharth, and J. Rosenberg, Colorectal carcinogenesis-update and perspectives, World Journal of Gastroenterology, vol.20, issue.48, pp.18151-64, 2014.
DOI : 10.3748/wjg.v20.i48.18151

S. Stryker, B. Wolff, C. Culp, S. Libbe, D. Ilstrup et al., Natural history of untreated colonic polyps, Gastroenterology, vol.93, issue.5, pp.1009-1022, 1987.
DOI : 10.1016/0016-5085(87)90563-4

J. Bargen, Chronic ulcerative colitis associated with malignant disease. Arch Surg, Oct, vol.117, issue.4, pp.561-76, 1928.

F. Edwards and S. Truelove, Course and prognosis of ulcerative colitis Part IV Carcinoma of the colon, Gut. Feb, vol.15, issue.1, pp.15-22, 1964.

J. Lennard-jones, D. Melville, B. Morson, J. Ritchie, and C. Williams, Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years., Gut, vol.31, issue.7, 1990.
DOI : 10.1136/gut.31.7.800

A. Ekbom, C. Helmick, M. Zack, and H. Adami, Ulcerative Colitis and Colorectal Cancer, New England Journal of Medicine, vol.323, issue.18, pp.1228-1261, 1990.
DOI : 10.1056/NEJM199011013231802

C. Bernstein, J. Blanchard, E. Kliewer, and A. Wajda, Cancer risk in patients with inflammatory bowel disease, Cancer, vol.77, issue.4, pp.854-62, 2001.
DOI : 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z

T. Jess, E. Loftus, . Jr, F. Velayos, W. Harmsen et al., Risk of Intestinal Cancer in Inflammatory Bowel Disease: A Population-Based Study From Olmsted County, Minnesota, Gastroenterology, vol.130, issue.4, pp.1039-1085, 2006.
DOI : 10.1053/j.gastro.2005.12.037

E. Langholz, P. Munkholm, M. Davidsen, and V. Binder, Colorectal cancer risk and mortality in patients with ulcerative colitis, Gastroenterology, vol.103, issue.5, pp.1444-51, 1992.
DOI : 10.1016/0016-5085(92)91163-X

K. Winther, J. T. Langholz, E. Munkholm, P. Binder, and V. , Long-term risk of cancer in ulcerative colitis: A population-based cohort study from Copenhagen County, Clinical Gastroenterology and Hepatology, vol.2, issue.12, pp.1088-95, 2004.
DOI : 10.1016/S1542-3565(04)00543-9

P. Manninen, A. Karvonen, J. Laukkarinen, P. Aitola, H. Huhtala et al., Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease, Scandinavian Journal of Gastroenterology, vol.48, issue.4, pp.423-431
DOI : 10.1016/j.crohns.2012.09.005

B. Lovasz, L. Lakatos, P. Golovics, G. David, T. Pandur et al., Risk of colorectal cancer in Crohn's disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary, J Gastrointest Liver Dis JGLD, 2013.

C. Castaño-milla, M. Chaparro, and J. Gisbert, Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis, Alimentary Pharmacology & Therapeutics, vol.19, issue.7, 2014.
DOI : 10.1111/apt.12651

L. Peyrin-biroulet, C. Lepage, V. Jooste, J. Guéant, J. Faivre et al., Colorectal cancer in inflammatory bowel diseases: A population-based study (1976???2008), Inflammatory Bowel Diseases, vol.18, issue.12, pp.2247-51, 1976.
DOI : 10.1002/ibd.22935

L. Beaugerie, M. Svrcek, P. Seksik, A. Bouvier, T. Simon et al., Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease The risk of colorectal cancer in ulcerative colitis: a meta-analysis, Gastroenterology. Gut, vol.14548, issue.14, pp.166-75, 2001.

T. Jess, M. Gamborg, P. Matzen, P. Munkholm, and T. Sørensen, Increased Risk of Intestinal Cancer in Crohn's Disease: A Meta-Analysis of Population-Based Cohort Studies, The American Journal of Gastroenterology, vol.107, issue.2, pp.2724-2733, 2005.
DOI : 10.1111/j.1572-0241.2003.08671.x

V. Roon, A. Reese, G. Teare, J. Constantinides, V. Darzi et al., The risk of cancer in patients with Crohn's disease. Dis Colon Rectum, pp.839-55, 2007.

J. Xie and S. Itzkowitz, Cancer in inflammatory bowel disease, World Journal of Gastroenterology, vol.14, issue.3, pp.378-89, 2008.
DOI : 10.3748/wjg.14.378

J. Dyson and M. Rutter, Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk?, World Journal of Gastroenterology, vol.18, issue.29, pp.3839-3887, 2012.
DOI : 10.3748/wjg.v18.i29.3839

J. Triantafillidis, G. Nasioulas, and P. Kosmidis, Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies, Anticancer Res, vol.29, issue.7, pp.2727-2764, 2009.

L. Herszényi, L. Barabás, P. Miheller, and Z. Tulassay, Colorectal Cancer in Patients with Inflammatory Bowel Disease: The True Impact of the Risk, Digestive Diseases, vol.33, issue.1, pp.52-59, 2015.
DOI : 10.1159/000368447

B. Vogelstein, E. Fearon, S. Hamilton, S. Kern, A. Preisinger et al., Genetic Alterations during Colorectal-Tumor Development, New England Journal of Medicine, vol.319, issue.9, pp.525-557, 1988.
DOI : 10.1056/NEJM198809013190901

S. Azer, Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development, European Journal of Gastroenterology & Hepatology, vol.25, issue.3, pp.271-81
DOI : 10.1097/MEG.0b013e32835b5803

T. Tahara, N. Inoue, T. Hisamatsu, K. Kashiwagi, H. Takaishi et al., Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis, Journal of Gastroenterology and Hepatology, vol.59, issue.5, pp.710-715, 2005.
DOI : 10.1136/gut.46.6.790

I. Fujiwara, M. Yashiro, N. Kubo, K. Maeda, and K. Hirakawa, Ulcerative Colitis-Associated Colorectal Cancer is Frequently Associated with the Microsatellite Instability Pathway, Diseases of the Colon & Rectum, vol.51, issue.9, pp.1387-94, 2008.
DOI : 10.1007/s10350-008-9212-9

M. Svrcek, J. El-bchiri, A. Chalastanis, E. Capel, S. Dumont et al., Specific Clinical and Biological Features Characterize Inflammatory Bowel Disease???Associated Colorectal Cancers Showing Microsatellite Instability, Journal of Clinical Oncology, vol.25, issue.27, pp.4231-4239, 2007.
DOI : 10.1200/JCO.2007.10.9744

URL : https://hal.archives-ouvertes.fr/hal-00815857

A. Roessner, D. Kuester, P. Malfertheiner, and R. Schneider-stock, Oxidative stress in ulcerative colitis-associated carcinogenesis, Pathology - Research and Practice, vol.204, issue.7, pp.511-535, 2008.
DOI : 10.1016/j.prp.2008.04.011

C. Stolfi, D. Fina, R. Caruso, F. Caprioli, M. Sarra et al., Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid, Biochemical Pharmacology, vol.75, issue.3, pp.668-76, 2008.
DOI : 10.1016/j.bcp.2007.09.020

J. Nathanson, N. Yadron, J. Farnan, S. Kinnear, J. Hart et al., p53 Mutations are Associated with Dysplasia and Progression of Dysplasia in Patients with Crohn???s Disease, Digestive Diseases and Sciences, vol.34, issue.Suppl 8, pp.474-80, 2008.
DOI : 10.1007/s10620-007-9886-1

D. Aust, J. Terdiman, R. Willenbucher, C. Chang, A. Molinaro-clark et al., The APC/?-catenin pathway in ulcerative colitis-related colorectal carcinomas, Cancer, vol.59, issue.5, pp.1421-1428, 2002.
DOI : 10.1002/cncr.10334

S. Kern, M. Redston, A. Seymour, C. Caldas, S. Powell et al., Molecular genetic profiles of colitis-associated neoplasms, Gastroenterology, vol.107, issue.2, 1994.
DOI : 10.1016/0016-5085(94)90167-8

M. Candela, S. Turroni, E. Biagi, F. Carbonero, S. Rampelli et al., Inflammation and colorectal cancer, when microbiota-host mutualism breaks, World Journal of Gastroenterology, vol.20, issue.4, pp.908-930, 2014.
DOI : 10.3748/wjg.v20.i4.908

C. Stolfi, A. Rizzo, E. Franzè, A. Rotondi, M. Fantini et al., Involvement of interleukin-21 in the regulation of colitis-associated colon cancer, The Journal of Experimental Medicine, vol.63, issue.11, pp.2279-90, 2011.
DOI : 10.1038/nri1995

R. Atreya and M. Neurath, Signaling molecules: the pathogenic role of the IL-6

A. Rizzo, M. Waldner, C. Stolfi, M. Sarra, D. Fina et al., Smad7 expression in T cells prevents colitis-associated cancer. Cancer Res, pp.7423-7455, 2011.

M. Fantini and F. Pallone, Cytokines: From Gut Inflammation to Colorectal Cancer, Current Drug Targets, vol.9, issue.5, pp.375-80, 2008.
DOI : 10.2174/138945008784221206

B. Flood, K. Oficjalska, D. Laukens, J. Fay, O. Grady et al., Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential, Clinical & Experimental Immunology, vol.125, issue.1, pp.39-50
DOI : 10.1111/cei.12617

S. Foersch, M. Neurath, U. Nitsche, A. Zimmermann, C. Späth et al., Colitis-associated neoplasia: molecular basis and clinical translation Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis, Cell Mol Life Sci CMLS Ann Surg, vol.57258, issue.5, pp.775-82, 2013.

R. Riddell, H. Goldman, D. Ransohoff, H. Appelman, C. Fenoglio et al., Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications, Human Pathology, vol.14, issue.11, pp.931-68, 1983.
DOI : 10.1016/S0046-8177(83)80175-0

A. Bressenot, V. Cahn, S. Danese, and L. Peyrin-biroulet, Microscopic features of colorectal neoplasia in inflammatory bowel diseases, World Journal of Gastroenterology, vol.20, issue.12, pp.3164-72, 2014.
DOI : 10.3748/wjg.v20.i12.3164

D. Allende, M. Elmessiry, W. Hao, G. Dasilva, S. Wexner et al., Interobserver and intra-observer variability in the diagnosis of dysplasia in patients with inflammatory bowel disease: correlation of pathological and endoscopic findings, Precancerous lesions in inflammatory bowel disease, pp.710-8257, 2014.

T. Ullman, V. Croog, N. Harpaz, D. Sachar, and S. Itzkowitz, Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis, Gastroenterology, vol.125, issue.5, 2003.
DOI : 10.1016/j.gastro.2003.08.023

M. Svrcek, J. Cosnes, L. Beaugerie, R. Parc, M. Bennis et al., Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis, Histopathology, vol.107, issue.5, pp.574-83, 2007.
DOI : 10.1136/gut.52.8.1127

M. Ouaïssi, L. Maggiori, A. Alves, U. Giger, I. Sielezneff et al., Colorectal cancer complicating inflammatory bowel disease: a comparative study of Crohn???s disease vs ulcerative colitis in 34 patients, Colorectal Disease, vol.130, issue.6, 2011.
DOI : 10.1111/j.1463-1318.2010.02241.x

S. Brackmann, S. Andersen, G. Aamodt, F. Langmark, O. Clausen et al., Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease, Scandinavian Journal of Gastroenterology, vol.120, issue.1, pp.46-55, 2009.
DOI : 10.1136/gut.2004.046615

J. Baars, E. Kuipers, M. Van-haastert, J. Nicolaï, A. Poen et al., Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey, Journal of Gastroenterology, vol.2, issue.746???74, 2012.
DOI : 10.1007/s00535-012-0603-2

M. Rutter, B. Saunders, K. Wilkinson, S. Rumbles, G. Schofield et al., Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis, Gastroenterology, vol.126, issue.2, pp.451-460, 2004.
DOI : 10.1053/j.gastro.2003.11.010

R. Gupta, N. Harpaz, S. Itzkowitz, S. Hossain, S. Matula et al., Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study, Gastroenterology, vol.133, issue.4, pp.1099-105, 2007.
DOI : 10.1053/j.gastro.2007.08.001

D. Rubin, D. Huo, J. Kinnucan, M. Sedrak, N. Mccullom et al., Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case???Control Study, Clinical Gastroenterology and Hepatology, vol.11, issue.12, pp.1601-1609
DOI : 10.1016/j.cgh.2013.06.023

R. Goldstone, S. Itzkowitz, N. Harpaz, and T. Ullman, Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location, Gastrointestinal Endoscopy, vol.74, issue.5, pp.1087-93, 2011.
DOI : 10.1016/j.gie.2011.06.028

V. Gumaste, D. Sachar, and A. Greenstein, Benign and malignant colorectal strictures in ulcerative colitis., Gut, vol.33, issue.7, pp.938-979, 1992.
DOI : 10.1136/gut.33.7.938

B. Lashner, B. Turner, D. Bostwick, P. Frank, and S. Hanauer, Dysplasia and cancer complicating strictures in ulcerative colitis, Digestive Diseases and Sciences, vol.76, issue.3, pp.349-52, 1990.
DOI : 10.1007/BF01537413

M. Fumery, G. De-chambrun, C. Stefanescu, A. Buisson, A. Bressenot et al., Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures, Clinical Gastroenterology and Hepatology, vol.13, issue.10, 2015.
DOI : 10.1016/j.cgh.2015.04.185

URL : https://hal.archives-ouvertes.fr/hal-01154234

U. Navaneethan, R. Jegadeesan, N. Gutierrez, P. Venkatesh, A. Arrossi et al., Backwash Ileitis and the Risk of Colon Neoplasia in Ulcerative Colitis Patients Undergoing Restorative Proctocolectomy, Digestive Diseases and Sciences, vol.106, issue.7, pp.2019-2046
DOI : 10.1007/s10620-013-2571-7

K. Nuako, D. Ahlquist, D. Mahoney, D. Schaid, D. Siems et al., Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study, Gastroenterology, vol.115, issue.5
DOI : 10.1016/S0016-5085(98)70077-0

V. Bergeron, A. Vienne, H. Sokol, P. Seksik, I. Nion-larmurier et al., Risk Factors for Neoplasia in Inflammatory Bowel Disease Patients With Pancolitis, The American Journal of Gastroenterology, vol.85, issue.11, pp.2405-2416, 2010.
DOI : 10.1053/j.gastro.2007.08.001

URL : https://hal.archives-ouvertes.fr/hal-00601826

J. Askling, P. Dickman, P. Karlén, O. Broström, A. Lapidus et al., Family history as a risk factor for colorectal cancer in inflammatory bowel disease, Gastroenterology, vol.120, issue.6, pp.1356-62, 2001.
DOI : 10.1053/gast.2001.24052

U. Broomé, G. Lindberg, and R. Löfberg, Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology, pp.1877-80, 1992.

D. Kornfeld, A. Ekbom, and T. Ihre, Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study, Gut, vol.41, issue.4, pp.522-527, 1997.
DOI : 10.1136/gut.41.4.522

H. Jayaram, J. Satsangi, and R. Chapman, Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?, Gut, vol.48, issue.3, 2001.
DOI : 10.1136/gut.48.3.430

R. Soetikno, O. Lin, P. Heidenreich, H. Young, and M. Blackstone, Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis, Gastrointestinal Endoscopy, vol.56, issue.1, pp.48-54, 2002.
DOI : 10.1067/mge.2002.125367

R. Wang and R. Leong, Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature

O. Toole, A. Walsh, P. Keegan, D. Byrne, K. Doherty et al., Mortality in inflammatory bowel disease patients under 65 years of age, Scand J Gastroenterol, 2014.

X. Roblin, E. Germain, J. Phelip, V. Ducros, J. Pofelski et al., Factors associated with hyperhomocysteinemia in inflammatory bowel disease: prospective study in 81 patients]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, Feb, vol.27, issue.2, pp.106-116, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00410548

J. Phelip, V. Ducros, J. Faucheron, B. Flourie, and X. Roblin, Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease, Inflammatory Bowel Diseases, vol.14, issue.2, pp.242-250, 2008.
DOI : 10.1002/ibd.20309

F. Van-duijnhoven, H. Bueno-de-mesquita, P. Ferrari, M. Jenab, H. Boshuizen et al., Fruit, vegetables, and colorectal cancer risk: the European Prospective Investigation into Cancer and Nutrition, American Journal of Clinical Nutrition, vol.89, issue.5, pp.1441-52, 2009.
DOI : 10.3945/ajcn.2008.27120

L. Marchand, L. Wilkens, L. Kolonel, L. Hankin, J. Lyu et al., Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer, Cancer Res, vol.57, issue.21, pp.4787-94, 1997.

A. Leufkens, F. Van-duijnhoven, P. Siersema, H. Boshuizen, A. Vrieling et al., Cigarette Smoking and Colorectal Cancer Risk in the European Prospective Investigation Into Cancer and Nutrition Study, Clinical Gastroenterology and Hepatology, vol.9, issue.2, pp.137-181, 2011.
DOI : 10.1016/j.cgh.2010.10.012

C. Johnson, C. Wei, J. Ensor, D. Smolenski, C. Amos et al., Meta-analyses of colorectal cancer risk factors. Cancer Causes Control CCC, pp.1207-1229, 2013.

L. Biedermann, J. Zeitz, J. Mwinyi, E. Sutter-minder, A. Rehman et al., Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans, PLoS ONE, vol.6, issue.3
DOI : 10.1371/journal.pone.0059260.s014

L. Beaugerie, Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?, Gut, vol.61, issue.4, pp.476-83
DOI : 10.1136/gutjnl-2011-301133

URL : https://hal.archives-ouvertes.fr/hal-00680901

L. Beaugerie, F. Carrat, J. Colombel, A. Bouvier, H. Sokol et al., Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer, Gut, vol.95, issue.9, pp.1416-1439, 2014.
DOI : 10.1136/gutjnl-2013-305763

URL : https://hal.archives-ouvertes.fr/hal-00877944

J. Gong, L. Zhu, Z. Guo, Y. Li, W. Zhu et al., Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis):e81487. 99. Chapman CG, Rubin DT. The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease, PloS One. Gastrointest Endosc Clin N Am, vol.824, issue.113, pp.353-65, 2013.

L. Peyrin-biroulet, A. Oussalah, N. Williet, C. Pillot, L. Bresler et al., Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease, Gut, vol.60, issue.7, pp.930-936, 2011.
DOI : 10.1136/gut.2010.227884

D. Rubin, M. Cruz-correa, C. Gasche, J. Jass, G. Lichtenstein et al., Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: A clinical review and update, Inflammatory Bowel Diseases, vol.14, issue.2, pp.265-74, 2008.
DOI : 10.1002/ibd.20297

P. Rothwell, M. Wilson, C. Elwin, B. Norrving, A. Algra et al., Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials, The Lancet, vol.376, issue.9754, pp.1741-50, 2010.
DOI : 10.1016/S0140-6736(10)61543-7

D. Pinczowski, A. Ekbom, J. Baron, J. Yuen, and H. Adami, Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study, Gastroenterology, vol.107, issue.1, 1994.
DOI : 10.1016/0016-5085(94)90068-X

T. Van-staa, T. Card, R. Logan, and H. Leufkens, 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study, Gut, vol.54, issue.11, pp.1573-1581, 2005.
DOI : 10.1136/gut.2005.070896

J. Terdiman, M. Steinbuch, W. Blumentals, T. Ullman, and D. Rubin, 5-Aminosalicylic Acid Therapy and the Risk of Colorectal Cancer Among Patients with Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.13, issue.4, pp.367-71, 2007.
DOI : 10.1002/ibd.20074

G. Nguyen, A. Gulamhusein, and C. Bernstein, 5-Aminosalicylic Acid Is Not Protective Against Colorectal Cancer in Inflammatory Bowel Disease: A Meta-Analysis of Non-Referral Populations, The American Journal of Gastroenterology, vol.107, issue.9, pp.1298-304, 2012.
DOI : 10.1053/j.gastro.2010.02.007

C. Bernstein, Z. Nugent, and J. Blanchard, 5-Aminosalicylate Is Not Chemoprophylactic for Colorectal Cancer in IBD: A Population Based Study, The American Journal of Gastroenterology, vol.107, issue.4, 2011.
DOI : 10.1016/S0140-6736(94)90813-3

S. Singh, S. Khanna, D. Pardi, E. Loftus, and J. Talwalkar, Effect of Ursodeoxycholic Acid Use on the Risk of Colorectal Neoplasia in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease, Inflammatory Bowel Diseases, vol.19, issue.8, pp.1631-1639
DOI : 10.1097/MIB.0b013e318286fa61

G. Lichtenstein, B. Feagan, R. Cohen, B. Salzberg, R. Diamond et al., Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT??? Registry, The American Journal of Gastroenterology, vol.31, issue.2, pp.212-235, 2014.
DOI : 10.3899/jrheum.100347

J. Hansen, S. Kumar, W. Lo, D. Poulsen, U. Halai et al., Ursodiol and Colorectal Cancer or Dysplasia Risk in Primary Sclerosing Cholangitis and Inflammatory Bowel Disease: A Meta-Analysis, Digestive Diseases and Sciences, vol.52, issue.11, pp.3079-87, 2013.
DOI : 10.1007/s10620-013-2772-0

S. Grundfest, V. Fazio, R. Weiss, D. Jagelman, I. Lavery et al., The Risk of Cancer Following Colectomy and Ileorectal Anastomosis for Extensive Mucosal Ulcerative Colitis, Annals of Surgery, vol.193, issue.1, pp.9-14, 1981.
DOI : 10.1097/00000658-198101000-00002

K. Winther, E. Bruun, B. Federspiel, P. Guldberg, V. Binder et al., Screening for dysplasia and TP53 mutations in closed rectal stumps of patients with ulcerative colitis or Crohn disease, Scandinavian Journal of Gastroenterology, vol.87, issue.3, pp.232-239, 2004.
DOI : 10.1016/S0046-8177(83)80175-0

P. Buchmann, R. Allan, H. Thompson, A. , and J. , Carcinoma in a rectovaginal fistula in a patient with Crohn's disease, The American Journal of Surgery, vol.140, issue.3, pp.462-465, 1980.
DOI : 10.1016/0002-9610(80)90190-7

I. Iesalnieks, W. Gaertner, H. Glass, U. Strauch, M. Hipp et al., Fistulaassociated anal adenocarcinoma in Crohn's disease, Inflamm Bowel Dis, 2010.

M. Imam, J. Eaton, J. Puckett, E. Loftus, K. Mathis et al., Neoplasia in the ileoanal pouch following colectomy in patients with ulcerative colitis and primary sclerosing cholangitis, Journal of Crohn's and Colitis, vol.8, issue.10, 2014.
DOI : 10.1016/j.crohns.2014.03.011

P. Choi, F. Nugent, D. Schoetz, M. Silverman, and R. Haggitt, Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis, Gastroenterology, vol.105, issue.2, pp.418-442, 1993.
DOI : 10.1016/0016-5085(93)90715-O

A. Ananthakrishnan, A. Cagan, T. Cai, V. Gainer, S. Shaw et al., Colonoscopy Is Associated With a Reduced Risk for Colon Cancer and Mortality in Patients With Inflammatory Bowel Diseases, Clinical Gastroenterology and Hepatology, vol.13, issue.2, pp.322-331, 2015.
DOI : 10.1016/j.cgh.2014.07.018

Y. Wang, J. Cangemi, E. Loftus, and M. Picco, Use of Surveillance Colonoscopy in Medicare Patients with Inflammatory Bowel Disease prior to Colorectal Cancer Diagnosis, Digestion, vol.90, issue.1, pp.58-62, 2014.
DOI : 10.1159/000363053

C. Bernstein, Challenges in designing a randomized trial of surveillance colonoscopy in IBD, Inflamm Bowel Dis, vol.4, issue.2, pp.132-173, 1998.

P. Collins, C. Mpofu, A. Watson, and J. Rhodes, Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease, Cochrane Database Syst Rev, issue.2, p.279, 2006.

S. Shah, D. Rubin, and F. Farraye, Chromoendoscopy for Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Disease, Current Gastroenterology Reports, vol.19, issue.9, p.407, 2014.
DOI : 10.1007/s11894-014-0407-z

E. Mooiweer, A. Van-der-meulen-de-jong, C. Ponsioen, H. Fidder, P. Siersema et al., Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study, The American Journal of Gastroenterology, vol.79, issue.7, 2015.
DOI : 10.1038/ajg.2015.63

T. Bessissow and R. Bisschops, Advanced endoscopic imaging for dysplasia surveillance in ulcerative colitis, Expert Review of Gastroenterology & Hepatology, vol.7, issue.1, pp.57-67
DOI : 10.1586/egh.12.65

E. Kim and D. Chang, Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis, World Journal of Gastroenterology, vol.20, issue.29, pp.9872-81, 2014.
DOI : 10.3748/wjg.v20.i29.9872

M. Lutgens, S. Vermeire, M. Van-oijen, F. Vleggaar, P. Siersema et al., A Rule for Determining Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, vol.13, issue.1
DOI : 10.1016/j.cgh.2014.06.032

R. Gore, E. Balthazar, G. Ghahremani, and F. Miller, CT features of ulcerative colitis and Crohn's disease., American Journal of Roentgenology, vol.167, issue.1, pp.3-15, 1996.
DOI : 10.2214/ajr.167.1.8659415

D. Regge, E. Neri, F. Turini, and G. Chiara, Role of CT colonography in inflammatory bowel disease, European Journal of Radiology, vol.69, issue.3, pp.404-412, 2009.
DOI : 10.1016/j.ejrad.2008.11.027

T. Bonaventure, D. Goéré, V. Boige, and M. Pocard, Beware of PET-CT results in cases of cancer occurring in the setting of chronic inflammatory bowel disease], J Chir, 2009.

V. Roon, A. Karamountzos, L. Purkayastha, S. Reese, G. Darzi et al., Diagnostic Precision of Fecal Calprotectin for Inflammatory Bowel Disease and Colorectal Malignancy, The American Journal of Gastroenterology, vol.174, issue.4, pp.803-816, 2007.
DOI : 10.1046/j.1365-2036.2002.01242.x

F. Farraye, R. Odze, J. Eaden, and S. Itzkowitz, AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease, Gastroenterology, vol.138, issue.2, pp.746-74, 2010.
DOI : 10.1053/j.gastro.2009.12.035

J. Eaden and J. Mayberry, British Society for Gastroenterology, Association of Coloproctology for Great Britain and Ireland. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease, Gut, 2002.

M. Lutgens, M. Van-oijen, E. Mooiweer, M. Van-der-valk, F. Vleggaar et al., A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines, Gastrointestinal Endoscopy, vol.80, issue.5, pp.842-850, 2014.
DOI : 10.1016/j.gie.2014.02.1031

L. Peyrin-biroulet, G. Bonnaud, A. Bourreille, J. Chevaux, P. Faure et al., Recommendations Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED), Endoscopy, vol.45, issue.11, pp.936-979, 2013.
DOI : 10.1055/s-0033-1344783

L. Vuitton, F. Gonzalez, and S. Koch, Surveillance endoscopique de la dysplasie dans les maladies inflammatoires chroniques de l'intestin. Acta Endosc, pp.207-220, 2013.

S. Gorfine, J. Bauer, M. Harris, and I. Kreel, Dysplasia complicating chronic ulcerative colitis, Diseases of the Colon & Rectum, vol.43, issue.11, pp.1575-81, 2000.
DOI : 10.1007/BF02236742

J. Kwah and F. Farraye, Current and Future Status for Evaluation of Dysplasia and Carcinoma in IBD, Current Treatment Options in Gastroenterology, vol.11, issue.3, pp.90-102, 2014.
DOI : 10.1007/s11938-013-0006-3

M. Blackstone, R. Riddell, B. Rogers, and B. Levin, Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy, Gastroenterology. Feb, vol.80, issue.2, pp.366-74, 1981.

S. Itzkowitz and N. Harpaz, Diagnosis and management of dysplasia in patients with inflammatory bowel diseases, Gastroenterology, vol.126, issue.6, pp.1634-1682, 2004.
DOI : 10.1053/j.gastro.2004.03.025

C. Bernstein, F. Shanahan, and W. Weinstein, Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet, pp.71-75, 1994.

A. Ekbom, Motion - Colonoscopic Surveillance is more Cost Effective than Colectomy in Patients with Ulcerative Colitis: Arguments Against the Motion, Canadian Journal of Gastroenterology, vol.17, issue.2, pp.122-126, 2003.
DOI : 10.1155/2003/149259

D. Provenzale, K. Kowdley, S. Arora, and J. Wong, Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis, Gastroenterology, vol.109, issue.4, 1995.
DOI : 10.1016/0016-5085(95)90578-2

G. Slaney and B. Brooke, CANCER IN ULCERATIVE COLITIS, The Lancet, vol.274, issue.7105, pp.694-702, 1959.
DOI : 10.1016/S0140-6736(59)92130-0

A. Ekbom, C. Helmick, M. Zack, L. Holmberg, and H. Adami, Survival and causes of death in patients with inflammatory bowel disease: A population-based study, Gastroenterology, vol.103, issue.3, pp.954-60, 1992.
DOI : 10.1016/0016-5085(92)90029-X

J. Hrabe, J. Byrn, A. Button, G. Zamba, M. Kapadia et al., A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome, Journal of Surgical Oncology, vol.20, issue.2, pp.117-138, 2014.
DOI : 10.1002/jso.23465

A. Jensen, M. Larsen, M. Gislum, M. Skriver, P. Jepsen et al., Survival After Colorectal Cancer in Patients with Ulcerative Colitis: A Nationwide Population-Based Danish Study, The American Journal of Gastroenterology, vol.44, issue.6, pp.1283-1290, 2006.
DOI : 10.1023/B:CACO.0000007970.04094.76

J. Ritchie, P. Hawley, and J. Lennard-jones, Prognosis of carcinoma in ulcerative colitis., Gut, vol.22, issue.9, pp.752-757, 1981.
DOI : 10.1136/gut.22.9.752

T. Watanabe, T. Konishi, J. Kishimoto, K. Kotake, T. Muto et al., Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: A nationwide Japanese study, Inflammatory Bowel Diseases, vol.17, issue.3, pp.802-810, 2011.
DOI : 10.1002/ibd.21365

M. Larsen, H. Mose, M. Gislum, M. Skriver, P. Jepsen et al., Survival After Colorectal Cancer in Patients with Crohn's Disease: A Nationwide Population-Based Danish Follow-Up Study, The American Journal of Gastroenterology, vol.31, issue.1, pp.163-170, 2007.
DOI : 10.1002/bjs.4978

B. Renz, W. Thasler, G. Preissler, H. T. Khalil, P. Mikhailov et al., Clinical Outcome of IBD-Associated versus Sporadic Colorectal Cancer: A Matched-Pair Analysis, Journal of Gastrointestinal Surgery, vol.118, issue.Suppl 2, pp.981-90, 2013.
DOI : 10.1007/s11605-013-2171-z

Y. Ziv, V. Fazio, S. Strong, J. Oakley, J. Milsom et al., Ulcerative colitis and coexisting colorectal cancer: Recurrence rate after restorative proctocolectomy, Annals of Surgical Oncology, vol.52, issue.(suppl)170, pp.512-517, 1994.
DOI : 10.1007/BF02303617

S. Brackmann, S. Andersen, G. Aamodt, B. Roald, F. Langmark et al., Two distinct groups of colorectal cancer in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.15, issue.1, pp.9-16, 2009.
DOI : 10.1002/ibd.20542

S. Green, R. Stock, and A. Greenstein, Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.44, issue.4, pp.835-875, 1999.
DOI : 10.1016/S0360-3016(99)00091-7

B. Chang, A. Kumar, S. Koyfman, M. Kalady, I. Lavery et al., Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: Risks and benefits, International Journal of Colorectal Disease, vol.17, issue.3, 2015.
DOI : 10.1007/s00384-014-2103-8

A. Tiersten and L. Saltz, Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy., Journal of Clinical Oncology, vol.14, issue.7, pp.2043-2049, 1996.
DOI : 10.1200/JCO.1996.14.7.2043

O. Bernheim, J. Colombel, T. Ullman, D. Laharie, L. Beaugerie et al., The management of immunosuppression in patients with inflammatory bowel disease and cancer, Gut, vol.96, issue.11
DOI : 10.1136/gutjnl-2013-305300

URL : https://hal.archives-ouvertes.fr/hal-00850160

T. Lecomte, Thésaurus National de Cancérologie Digestive -3. Cancer du colon

J. Gerard, Thésaurus National de Cancérologie Digestive -5. Cancer du rectum

F. Remzi and M. Preen, Rectal cancer and ulcerative colitis: does it change the therapeutic approach? Colorectal Dis Off J Assoc Coloproctology G B Irel, 2003.

T. Connelly and W. Koltun, The surgical treatment of inflammatory bowel disease-associated dysplasia, Expert Review of Gastroenterology & Hepatology, vol.7, issue.4, pp.307-328, 2013.
DOI : 10.1586/egh.13.17

J. Lennard-jones, Colitic cancer: supervision, surveillance, or surgery? Gastroenterology, pp.1388-91, 1995.

R. Kiran, P. Nisar, J. Goldblum, V. Fazio, F. Remzi et al., Dysplasia associated with Crohn's colitis: segmental colectomy or more extended resection? Ann Surg, pp.221-227, 2012.

J. Lindberg, R. Stenling, R. Palmqvist, and J. Rutegård, Surgery for neoplastic changes in ulcerative colitis ??? can limited resection be justified? Outcome for patients who underwent limited surgery, Colorectal Disease, vol.240, issue.7, pp.551-557, 2006.
DOI : 10.1006/jsre.2001.6171

A. Wibmer, A. Kroesen, J. Gröne, N. Slavova, A. Weinhold et al., Predictors of permanent ileostomy after restorative proctocolectomy, British Journal of Surgery, vol.238, issue.Suppl 1, pp.1561-1567, 2010.
DOI : 10.1002/bjs.7135

Y. Ziv, V. Fazio, M. Sirimarco, I. Lavery, J. Goldblum et al., Incidence, risk factors, and treatment of dysplasia in the anal transitional zone after ileal pouch-anal anastomosis, Diseases of the Colon & Rectum, vol.37, issue.12, pp.1281-1286, 1994.
DOI : 10.1007/BF02257797

Y. Panis, B. Poupard, J. Nemeth, A. Lavergne, P. Hautefeuille et al., Ileal pouch/anal anastomosis for Crohn's disease. Lancet, pp.854-861, 1996.

L. Maggiori, A. Khayat, X. Treton, Y. Bouhnik, E. Vicaut et al., Laparoscopic Approach for Inflammatory Bowel Disease Is a Real Alternative to Open Surgery, Annals of Surgery, vol.260, issue.2, pp.305-315, 2014.
DOI : 10.1097/SLA.0000000000000534

V. Fazio, F. Marchetti, M. Church, J. Goldblum, C. Lavery et al., Effect of Resection Margins on the Recurrence of Crohn's Disease in the Small Bowel, Annals of Surgery, vol.224, issue.4, pp.563-71, 1996.
DOI : 10.1097/00000658-199610000-00014

R. Heald, E. Husband, and R. Ryall, The mesorectum in rectal cancer surgery???the clue to pelvic recurrence?, British Journal of Surgery, vol.26, issue.10, pp.613-619, 1982.
DOI : 10.1002/bjs.1800691019

T. Holm, A. Ljung, T. Häggmark, G. Jurell, and J. Lagergren, Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer, British Journal of Surgery, vol.105, issue.2, pp.232-240, 2007.
DOI : 10.1002/bjs.5489

D. Dindo, N. Demartines, and P. Clavien, Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, 2004.
DOI : 10.1097/01.sla.0000133083.54934.ae

P. Rutgeerts, K. Geboes, G. Vantrappen, J. Beyls, R. Kerremans et al., Predictability of the postoperative course of Crohn's disease, Gastroenterology, vol.99, issue.4, pp.956-63, 1990.
DOI : 10.1016/0016-5085(90)90613-6

H. Mann and D. Whitney, On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other, The Annals of Mathematical Statistics, vol.18, issue.1, pp.50-60, 1947.
DOI : 10.1214/aoms/1177730491

D. Cox, Regression Models and Life-Tables, Journal Of The Royal Statistical Society
DOI : 10.1007/978-1-4612-4380-9_37

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, pp.457-81, 1958.

N. Mantel, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother Rep, vol.50, issue.3, pp.163-70, 1966.

J. Cosnes, C. Gower-rousseau, P. Seksik, and A. Cortot, Epidemiology and Natural History of Inflammatory Bowel Diseases, Gastroenterology, vol.140, issue.6, pp.1785-94, 2011.
DOI : 10.1053/j.gastro.2011.01.055

URL : https://hal.archives-ouvertes.fr/hal-00631553

R. Kiran, A. Ali, U. Nisar, P. Khoury, W. Gu et al., Risk and Location of Cancer in Patients With Preoperative Colitis-Associated Dysplasia Undergoing Proctocolectomy, Annals of Surgery, vol.259, issue.2, 2013.
DOI : 10.1097/SLA.0b013e31828e7417

T. Delaunoit, P. Limburg, R. Goldberg, J. Lymp, E. Loftus et al., Colorectal Cancer Prognosis Among Patients With Inflammatory Bowel Disease, Clinical Gastroenterology and Hepatology, vol.4, issue.3, pp.335-377, 2006.
DOI : 10.1016/j.cgh.2005.12.035

G. Lee, G. Malietzis, A. Askari, D. Bernardo, H. Hassi et al., Is right-sided colon cancer different to left-sided colorectal cancer? ??? A systematic review, European Journal of Surgical Oncology (EJSO), vol.41, issue.3, pp.300-308
DOI : 10.1016/j.ejso.2014.11.001

M. Svrcek, J. Fontugne, A. Duval, and J. Fléjou, Inflammatory Bowel Disease???associated Colorectal Cancers and Microsatellite Instability, The American Journal of Surgical Pathology, vol.37, issue.3, pp.460-462, 2013.
DOI : 10.1097/PAS.0b013e31827ae150

URL : https://hal.archives-ouvertes.fr/hal-00815857

T. Judge, J. Lewis, and G. Lichtenstein, Colonic dysplasia and cancer in inflammatory bowel disease, Gastrointestinal Endoscopy Clinics of North America, vol.12, issue.3, pp.495-523, 2002.
DOI : 10.1016/S1052-5157(02)00014-4

C. Mescoli, M. Frego, and M. Rugge, Pathology of dysplasia and cancer in inflammatory bowel disease, Ann Ital Chir Feb, vol.82, issue.1, pp.11-19, 2011.

R. Kiran, W. Khoury, J. Church, I. Lavery, V. Fazio et al., Colorectal Cancer Complicating Inflammatory Bowel Disease, Annals of Surgery, vol.252, issue.2, 2010.
DOI : 10.1097/SLA.0b013e3181e61e69

N. Andersen and J. T. , Has the risk of colorectal cancer in inflammatory bowel disease decreased?, World Journal of Gastroenterology, vol.19, issue.43, pp.7561-7569, 2013.
DOI : 10.3748/wjg.v19.i43.7561

T. Jess, A. Lopez, M. Andersson, L. Beaugerie, and L. Peyrin-biroulet, Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis, Clinical Gastroenterology and Hepatology, vol.12, issue.11, 2014.
DOI : 10.1016/j.cgh.2014.05.019

URL : https://hal.archives-ouvertes.fr/hal-01003172

S. Söderlund, L. Brandt, A. Lapidus, P. Karlén, O. Broström et al., Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease, Gastroenterology, vol.136, issue.5
DOI : 10.1053/j.gastro.2009.01.064

A. Sugita, D. Sachar, C. Bodian, M. Ribeiro, A. Aufses et al., Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval., Gut, vol.32, issue.2, pp.167-176, 1991.
DOI : 10.1136/gut.32.2.167

T. Jess, E. Loftus, . Jr, F. Velayos, K. Winther et al., Risk Factors for Colorectal Neoplasia in Inflammatory Bowel Disease: A Nested Case?Control Study From Copenhagen County, Denmark and Olmsted County, Minnesota, The American Journal of Gastroenterology, vol.46, issue.4, pp.829-865, 2007.
DOI : 10.1136/gut.2003.018515

R. Hughes, T. Hall, G. Block, B. Levin, and A. Moossa, The prognosis of carcinoma of the colon and rectum complicating ulcerative colitis, Surg Gynecol Obstet, 1978.

J. Van-heerden and R. Beart, Carcinoma of the colon and rectum complicating chronic ulcerative colitis, Diseases of the Colon & Rectum, vol.23, issue.3, pp.155-164, 1980.
DOI : 10.1007/BF02587618

I. Lavery, R. Chiulli, D. Jagelman, V. Fazio, and F. Weakley, Survival with Carcinoma Arising in Mucosal Ulcerative Colitis, Annals of Surgery, vol.195, issue.4, pp.508-520, 1982.
DOI : 10.1097/00000658-198204000-00021

S. Gyde, P. Prior, H. Thompson, J. Waterhouse, and R. Allan, Survival of patients with colorectal cancer complicating ulcerative colitis. Gut, pp.228-259, 1984.

A. Sugita, A. Greenstein, M. Ribeiro, D. Sachar, C. Bodian et al., Survival with Colorectal Cancer in Ulcerative Colitis A Study of 102 Cases, Annals of Surgery, vol.218, issue.2, 1993.
DOI : 10.1097/00000658-199308000-00011

. Actually, IBD-CRC) is not yet well-known and surgical strategy is not self-apparent